|
Index of reports
> Cases resulting in life threatening events (27)
Below is the selection of adverse event reports related to Epivir (Lamivudine) that includes cases resulting in life threatening events.
Reports 1 - 25 of 27 Next >>
Adverse event in 37 year old female receiving Epivir (Lamivudine)
Reported by a physician from Italy on 2007-10-12
Patient: 37 year old female
Adverse reactions / side effects: Lactic Acidosis
Adverse event resulted in: life threatening event
Suspect drug(s):
Zerit
Administration route: Oral
Start date: 2006-07-04
End date: 2007-05-05
Epivir
Administration route: Oral
Start date: 2006-07-04
End date: 2007-05-05
Adverse event in 36 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-10-01
Patient: 36 year old male
Adverse reactions / side effects: Blood Urea Increased, AIDS Encephalopathy, Altered State of Consciousness, Blood Creatinine Increased, Renal Failure Chronic, Convulsion, Nephropathy
Adverse event resulted in: life threatening event
Suspect drug(s):
Ziagen
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2002-11-26
End date: 2007-03-17
Viread
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2003-05-20
End date: 2006-11-14
Epivir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2000-09-19
End date: 2007-03-17
Retrovir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2000-09-19
End date: 2006-12-11
Norvir
Dosage: 100mg as directed
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-04-07
End date: 2007-03-17
Norvir
Dosage: 200mg unknown
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2003-05-20
End date: 2003-11-10
Zithromax
Administration route: Oral
Indication: Opportunistic Infection Prophylaxis
Start date: 2002-04-09
Baktar
Administration route: Oral
Indication: Antifungal Prophylaxis
Start date: 2006-04-01
Tipranavir
Indication: Drug USE FOR Unknown Indication
Darunavir
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Unknown Drug; Unknown Drug
Adverse event in 2 month old male receiving Epivir (Lamivudine)
Reported by a physician from France on 2007-07-16
Patient: 2 month old male
Adverse reactions / side effects: Gastrointestinal Malformation, Heart Disease Congenital, Pregnancy
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Videx
Start date: 2001-06-12
End date: 2001-08-11
Retrovir
Start date: 2001-03-27
End date: 2001-08-11
Epivir
Start date: 2001-03-27
End date: 2001-08-11
Adverse event in male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-13
Patient: male
Adverse reactions / side effects: Heart Disease Congenital, Duodenal Atresia
Adverse event resulted in: life threatening event
Suspect drug(s):
Videx
Start date: 2001-06-12
End date: 2001-11-08
Retrovir
Start date: 2001-03-27
End date: 2001-11-08
Epivir
Start date: 2001-03-27
End date: 2001-11-08
Adverse event in 49 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-07-06
Patient: 49 year old male
Adverse reactions / side effects: Hepatic Encephalopathy, Spinal Compression Fracture, Hepatic Failure, Cerebellar Haemorrhage, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zerit
Dosage: 80mg daily (06-sep-2001-04-jul-2004), dose decreased 60mg daily (05-jul-2004-01-feb-2005)
Administration route: Oral
Indication: HIV Infection
Start date: 2001-09-06
End date: 2005-02-01
Videx EC
Administration route: Oral
Indication: HIV Infection
Start date: 2001-09-06
End date: 2004-07-04
Stocrin Caps
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-11
Viracept
Administration route: Oral
Indication: HIV Infection
Start date: 2001-09-06
End date: 2004-12-06
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-07
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-07
Other drugs received by patient: Monilac; Recombinate; Octocog Alpha; Tenormin; Losartan Potassium; Adalat; Diovan; Nifedipine; Octocog Alpha; Valsartan; Lactulose
Adverse event in 24 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-08
Patient: 24 year old male
Adverse reactions / side effects: Pulmonary Hypertension, Palpitations, Dizziness
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 1994-11-19
Efavirenz
Dosage: therapy stopped on 25-jul-2000, restarted on 25-sep-2000.
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-10-02
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2001-10-20
Indinivir Sulfate
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-08
End date: 2000-05-24
Ziagen
Dosage: therapy stopped on 25-jul-2000, restarted on 20-oct-2001.
Administration route: Oral
Start date: 2000-07-24
End date: 2001-10-27
Invirase
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
Ritonavir
Dosage: therapy stopped on 24-dec-2000, restarted on 01-apr-2005.
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-12-24
Lopinavir + Ritonavir
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2004-04-24
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
Other drugs received by patient: Factor Viii
Adverse event in 37 year old female receiving Epivir (Lamivudine)
Reported by a physician from Italy on 2007-06-06
Patient: 37 year old female
Adverse reactions / side effects: Abdominal Pain, Vomiting, Nausea, Acidosis
Adverse event resulted in: life threatening event
Suspect drug(s):
Zerit
Administration route: Oral
Start date: 2006-07-04
End date: 2007-05-05
Epivir
Administration route: Oral
Start date: 2006-07-04
End date: 2007-05-05
Adverse event in 24 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-06-05
Patient: 24 year old male
Adverse reactions / side effects: Pulmonary Hypertension, Dyspnoea, Palpitations, Asthenia, Pulmonary Artery Dilatation, Cardiomegaly
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-11-01
End date: 2000-12-24
Norvir
Administration route: Oral
Start date: 2004-04-25
Videx EC
Administration route: Oral
Indication: HIV Infection
Start date: 2001-07-21
End date: 2004-05-14
Stocrin
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
Stocrin
Administration route: Oral
Start date: 2000-09-25
End date: 2000-10-02
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2004-04-24
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 1994-12-19
End date: 2001-07-21
Zerit
Administration route: Oral
Start date: 1997-08-25
End date: 2001-10-20
Crixivan
Dosage: 800mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-18
End date: 2000-05-24
Invirase
Dosage: 800mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-12-24
Other drugs received by patient: Reyataz; Viread; Anti-Hemophilic Globulin; Ziagen
Adverse event in 40 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-05-10
Patient: 40 year old male
Adverse reactions / side effects: Stevens-Johnson Syndrome
Adverse event resulted in: life threatening event
Suspect drug(s):
Zerit
Dosage: therapy dates: 1996 to 2004, then 12-apr-2007 to 17-apr-2007
Administration route: Oral
Indication: HIV Infection
Start date: 2004-01-01
End date: 2007-04-17
Epivir
Dosage: therapy dates: 1996 to 2004, jun-2006 to unknown, 12-apr-2007 to 17-apr-2007
Administration route: Oral
Indication: HIV Infection
Start date: 2004-01-01
End date: 2007-04-17
Viramune
Administration route: Oral
Indication: HIV Infection
Start date: 2007-04-12
End date: 2007-04-17
Other drugs received by patient: Stocrin; Valtrex; Ziagen
Adverse event in 24 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-05-09
Patient: 24 year old male
Adverse reactions / side effects: Pulmonary Hypertension, Palpitations, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Dizziness
Adverse event resulted in: life threatening event
Suspect drug(s):
Crixivan
Dosage: 800 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-18
End date: 2000-05-24
Efavirenz
Dosage: 600 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
Efavirenz
Dosage: 600 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-09-25
End date: 2000-10-02
Didanosine
Dosage: 300 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 1999-11-01
CAP Stavudine
Dosage: 80 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
TAB [therapy Unspecified]
Dosage: 600 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
CAP Saquinavir Mesylate
Dosage: see image
Indication: HIV Infection
Start date: 1999-11-01
End date: 2000-03-18
CAP Saquinavir Mesylate
Dosage: see image
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-03-18
CAP Saquinavir Mesylate
Dosage: see image
Indication: HIV Infection
Start date: 2000-05-24
CAP Ritonavir
Dosage: see image
Indication: HIV Infection
Start date: 1999-06-19
End date: 1999-10-31
CAP Ritonavir
Dosage: see image
Indication: HIV Infection
Start date: 1999-11-01
End date: 2000-12-24
CAP Ritonavir
Dosage: see image
Indication: HIV Infection
Start date: 2005-04-01
Videx
Dosage: see image
Administration route: Oral
Indication: HIV Infection
Start date: 1994-12-19
End date: 1997-03-07
Videx
Dosage: see image
Administration route: Oral
Indication: HIV Infection
Start date: 1997-03-08
End date: 2001-07-21
Videx EC
Dosage: 400 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2001-07-22
End date: 2004-05-14
Ziagen
Dosage: 600 mg/daily po
Administration route: Oral
Start date: 2000-07-24
End date: 2000-07-25
Ziagen
Dosage: 600 mg/daily po
Administration route: Oral
Start date: 2001-10-20
End date: 2001-10-27
Kaletra
Dosage: 6 dose/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2004-04-24
Epivir
Dosage: 300 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
Other drugs received by patient: Factor Viii
Adverse event in 49 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-05-02
Patient: 49 year old male
Adverse reactions / side effects: Hepatic Encephalopathy, Spinal Compression Fracture, Hepatic Failure, Cerebellar Haemorrhage, Fall, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zerit
Dosage: 80mg daily (06-sep-2001-04-jul-2004), dose decreased 60mg daily (05-jul-2004-01-feb-2005)
Administration route: Oral
Indication: HIV Infection
Start date: 2001-09-06
End date: 2005-02-01
Videx EC
Administration route: Oral
Indication: HIV Infection
Start date: 2001-09-06
End date: 2005-02-01
Stocrin Caps
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-11
Viracept
Administration route: Oral
Indication: HIV Infection
Start date: 2001-09-06
End date: 2004-12-06
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-07
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-07
Other drugs received by patient: Monilac; Recombinate; Octocog Alpha; Tenormin; Losartan Potassium; Adalat; Diovan; Nifedipine; Octocog Alpha; Valsartan; Lactulose
Adverse event in 37 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-04-26
Patient: 37 year old male
Adverse reactions / side effects: Dysgeusia, Liver Function Test Abnormal, General Physical Health Deterioration, Neutropenia, Infection
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2006-04-06
End date: 2006-04-22
Epzicom
Administration route: Oral
Indication: HIV Infection
Start date: 2006-05-11
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2006-04-06
End date: 2006-04-22
Zerit
Dosage: 30mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2006-04-06
End date: 2006-04-22
Baktar
Administration route: Oral
Indication: Pneumocystis Jiroveci Pneumonia
Start date: 2006-03-23
End date: 2006-04-27
Diflucan
Dosage: 100mg per day
Administration route: Oral
Indication: Oral Candidiasis
Start date: 2006-04-13
End date: 2006-05-10
Other drugs received by patient: Stocrin; Itraconazole; Gaster; Predonine; Myslee; Fungizone; Benambax
Adverse event in 33 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-04-03
Patient: 33 year old male
Adverse reactions / side effects: Drug Eruption, Anaemia, Glucose Tolerance Impaired
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-09-13
Combivir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-10-19
End date: 2005-01-11
Zerit
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-09-13
End date: 2004-10-18
Viramune
Dosage: 400mg per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-09-13
End date: 2004-09-26
Kaletra
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-09-27
End date: 2004-10-18
Other drugs received by patient: Stocrin; Viread; Clarithromycin; Baktar; Unknown Drug; Ciprofloxacin; Ebutol
Adverse event in male receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from Japan on 2007-03-30
Patient: male
Adverse reactions / side effects: Drug Eruption, Glucose Tolerance Impaired
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Viramune
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-09-26
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-10-18
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-10-18
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-27
End date: 2004-10-18
Predonine
Indication: Drug Eruption
Start date: 2004-09-23
End date: 2004-09-26
Other drugs received by patient: Clarithromycin; Baktar
Adverse event in 24 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-03-16
Patient: 24 year old male
Adverse reactions / side effects: Pulmonary Hypertension, Dyspnoea
Adverse event resulted in: life threatening event
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-11-01
End date: 2000-12-24
Norvir
Administration route: Oral
Start date: 2004-04-25
Videx EC
Administration route: Oral
Indication: HIV Infection
Start date: 2001-07-21
End date: 2004-05-14
Stocrin
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
Stocrin
Administration route: Oral
Start date: 2000-09-25
End date: 2000-10-02
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2004-04-24
Other drugs received by patient: Reyataz; Viread; Cross Eight M
Adverse event in 60 year old female receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-02-26
Patient: 60 year old female
Adverse reactions / side effects: Acute Pulmonary Oedema, Cardiac Failure, Myocardial Infarction
Adverse event resulted in: life threatening event
Suspect drug(s):
Epivir
Administration route: Oral
Indication: HIV Infection
Kredex
Administration route: Oral
Indication: Arrhythmia
Videx
Administration route: Oral
Indication: HIV Infection
Aldactazine
Dosage: unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Plavix
Dosage: unk
Administration route: Oral
Indication: Acute Myocardial Infarction
Start date: 2006-10-01
Kaletra
Administration route: Oral
Indication: HIV Infection
Other drugs received by patient: LOW Molecular Weight Heparin
Adverse event in 60 year old female receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-02-26
Patient: 60 year old female
Adverse reactions / side effects: Arrhythmia Supraventricular, Urinary Tract Infection Enterococcal, Cardiac Failure, Pulmonary Oedema, Myocardial Infarction, Acinetobacter Bacteraemia
Adverse event resulted in: life threatening event
Suspect drug(s):
Videx EC
Administration route: Oral
Indication: HIV Infection
Plavix
Administration route: Oral
Indication: Acute Myocardial Infarction
Aldactazine
Administration route: Oral
Kredex
Administration route: Oral
Indication: Arrhythmia
Epivir
Administration route: Oral
Indication: HIV Infection
Kaletra
Administration route: Oral
Indication: HIV Infection
Adverse event in 55 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-02-26
Patient: 55 year old male, weighing 70.3 kg (154.7 pounds)
Adverse reactions / side effects: Drug Toxicity, Mitochondrial Cytopathy
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Epivir (Lamivudine)
Adverse event in 60 year old female receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from France on 2007-02-20
Patient: 60 year old female
Adverse reactions / side effects: Acute Pulmonary Oedema, Arrhythmia Supraventricular, Body Temperature Increased, Cardiac Failure, Myocardial Infarction, Asphyxia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Kredex
Dosage: 12.5mg per day
Administration route: Oral
Aldactazine
Administration route: Oral
Videx
Dosage: 250mg per day
Administration route: Oral
Indication: HIV Infection
Kaletra
Dosage: 400mg twice per day
Administration route: Oral
Indication: HIV Infection
Plavix
Administration route: Oral
Indication: Acute Myocardial Infarction
Adverse event in male receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from Japan on 2007-02-16
Patient: male
Adverse reactions / side effects: Drug Eruption, Glucose Tolerance Impaired
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Viramune
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-09-26
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-10-18
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-10-18
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-27
End date: 2004-10-18
Predonine
Indication: Drug Eruption
Start date: 2004-09-23
End date: 2004-09-26
Other drugs received by patient: Clarithromycin; Baktar
Adverse event in male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from Malaysia on 2007-02-12
Patient: male
Adverse reactions / side effects: Diarrhoea Neonatal, Hyperlactacidaemia, Anion GAP Increased, Coagulopathy, Dyskinesia, Blood Albumin Decreased, Prothrombin Time Prolonged, Neonatal Disorder, Activated Partial Thromboplastin Time Prolonged, Caesarean Section, Hepatic Encephalopathy, Vertical Infection Transmission, Gamma-Glutamyltransferase Increased, Developmental Delay, HIV Infection, Fever Neonatal, Abdominal Distension, Alanine Aminotransferase Increased, Vomiting Neonatal, Convulsion, Drug Exposure During Pregnancy, Dehydration, Aspartate Aminotransferase Increased, Maternal Condition Affecting Foetus, Ammonia Increased, Feeding Disorder
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Retrovir
Dosage: oral
Administration route: Oral
Epivir
Dosage: transplacentary
Indication: HIV Infection
Stavudine
Dosage: transplacentary
Indication: HIV Infection
Nevirapine
Dosage: transplacentary
Indication: HIV Infection
Retrovir
Dosage: transplacentary
Indication: HIV Infection
Adverse event in male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-01-23
Patient: male, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Dysarthria, Soliloquy, Leukoencephalomyelitis, Encephalopathy, Depressed Level of Consciousness, Disorientation, Cerebral Haemorrhage
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Ziagen
Dosage: 300mg twice per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Zerit
Dosage: 30mg twice per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Other drugs received by patient: Selbex; Landsen; Unknown Drug; Adona (AC-17); Carnaculin; Juvela Nicotinate; Novoseven; Tienam; Meropen; SOL-Melcort; Predonine; Diflucan
Adverse event in male receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from Japan on 2007-01-22
Patient: male
Adverse reactions / side effects: Drug Eruption, Glucose Tolerance Impaired
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Viramune
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-09-26
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-10-18
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-10-18
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-27
End date: 2004-10-18
Predonine
Indication: Drug Eruption
Start date: 2004-09-23
End date: 2004-09-26
Other drugs received by patient: Clarithromycin; Bactrim
Adverse event in 49 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from France on 2007-01-19
Patient: 49 year old male
Adverse reactions / side effects: White Blood Cell Count Decreased, Weight Decreased, Haemoglobin Decreased, Agranulocytosis, General Physical Health Deterioration, Pancytopenia, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
Ziagen
Dosage: 600mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
Triflucan
Dosage: 50mg per day
Administration route: Oral
Start date: 2006-12-01
End date: 2006-12-14
Moxifloxacin Hydrochloride
Dosage: 400mg per day
Administration route: Oral
Indication: Mycobacterial Infection
Start date: 2006-11-28
End date: 2006-12-11
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
Bactrim
Start date: 2006-01-01
End date: 2006-12-04
Other drugs received by patient: Clarithromycin; Ethambutol HCL; Valganciclovir HCL; Prazepam; Effexor
Adverse event in 50 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-18
Patient: 50 year old male
Adverse reactions / side effects: Agranulocytosis, Pancytopenia
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Moxifloxacin Hydrochloride
Dosage: total daily dose: 400 mg unit dose: 400 mg
Administration route: Oral
Indication: Mycobacterial Infection
Start date: 2006-11-29
End date: 2006-12-11
Triflucan
Dosage: unit dose: 50 mg
Administration route: Oral
Indication: Unevaluable Event
Start date: 2006-12-01
End date: 2006-12-11
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
End date: 2006-11-28
Norvir
Start date: 2006-12-02
End date: 2006-12-11
Epivir
Dosage: unit dose: 300 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
End date: 2006-11-28
Epivir
Start date: 2006-12-02
End date: 2006-12-15
Ziagen
Dosage: unit dose: 600 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
End date: 2006-11-28
Ziagen
Start date: 2006-12-02
End date: 2006-12-11
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
End date: 2006-11-28
Reyataz
Start date: 2006-12-02
End date: 2006-12-11
Other drugs received by patient: Bactrim; Bactrim; Clarithromycin; Ethambutol Hydrochloride; Cymevan; Rovalcyte; Prazepam; Effexor
Page 1 Next >>
|
